CIK 0001645113
- Large accelerated filer
NovoCure Ltd
Sign in to watch- Ticker
- NVCR
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Entity type
- Operating
- Phone
- +44 1534756700
- Business address
- NO. 4 THE FORUM, GRENVILLE STREET, ST. HELIER, Jersey
- 4 Exercise or conversion Chief Financial Officer acquired 17,968 shares (option exercise)
- 4 Open-market sale Chief Financial Officer sold 883 shares at $21.82 ($19,265)
- 4 Open-market sale Chief Operating Officer sold 294 shares at $21.82 ($6,414)
- 4 Open-market sale Chief Growth Officer sold 273 shares at $21.82 ($5,956)
- 4 Open-market sale Chief Financial Officer sold 1,144 shares at $30.25 ($34,607)
- 4 Grant or award Chief Innovation Officer acquired 305 shares (grant or award)
- 4 Grant or award Chief Operating Officer acquired 366 shares (grant or award)
- 4 Grant or award Chief Growth Officer acquired 367 shares (grant or award)
- 4 Grant or award Chief Human Resources Officer acquired 357 shares (grant or award)
- 4 Grant or award General Counsel acquired 288 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 367 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 367 shares (grant or award)
- 4 Grant or award Director acquired 3,853 shares (grant or award)
- 4 Grant or award Director acquired 3,853 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 3,853 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 8 of 39 · 780 filings